The Future with AI

Navigating the Impact of AI in Brazil and the World

Episode 2

Hosted by

Pedro Folque De Almeida and Ana Claudia Reis

Kingsley Gate 360 aims to be a space for open debate between leading Brazilian executives on the most varied subjects with relevance and direct impact in Brazil and contemporary societies in general.

In this edition, Dennis Herszkowicz, David Schlesinger and Ana Cláudia Reis talk about artificial intelligence and its contribution to the progress of humanity. They also address regulatory challenges in Brazil and other countries; give their opinions on what could be replaced by artificial intelligence and what the impact of this would be in the future.

Key Highlights from Episode 2

Our esteemed panelists delve into the following key topics relevant to AI and its impact on Brazil.

Artificial Intelligence: Here to Stay

AI is a permanent fixture in our technological landscape. The discussion emphasizes AI's profound impact on nearly every aspect of human activity.

AI Regulation

Learn the complexities and challenges in regulating artificial intelligence, focusing on the difficulties posed by the rapid pace of technological advancements.

What can AI replace?

Explore the types of jobs and tasks that AI is likely to replace and the implications for the workforce and future job markets.

Technology and Globalization

Discover the interconnected impacts of technology and globalization and how these forces shape economies and societies worldwide.

Brazil and AI

Gain insights into how the regulatory approaches of the USA and China to AI could influence Brazil and examine the potential implications for Brazil's AI regulation and adoption.

Meet Our Guests

Dennis Herszkowicz

CEO, TOTVS

Dennis Herszkowicz is CEO of TOTVS, the largest technology company in Brazil. Throughout his career, he has added strategic thinking, execution discipline, in-depth financial knowledge, a constant eye for innovation and genuine care for customers and employees, presenting strong performances at TOTVS and Linx since 2003. Dennis has a degree in Marketing from ESPM.

David Schlesinger

Co-founder and CEO, Mendelics

David Schlesinger is Co-founder and CEO of Mendelics, the first laboratory in Latin America dedicated to genomic analysis, focusing mainly on the clinical diagnosis of rare diseases and hereditary cancer. Graduated in medicine from the Faculty of Medicine of USP, clinical neurologist from Hospital das Clínicas of FMUSP and Ph.D. in genetics from USP. The main lines of research are the analysis of the human genome, genetics of Mendelian and complex diseases, bioinformatics, and personalized medicine.

Contáctenos

I want to grow my career

I would like my candidacy to be considered for executive-level opportunities

I am representing a company

I would like to discuss how Kingsley Gate can help me hire executives for my company

Kingsley Gate Partners, LLC is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
By clicking submit below, you consent to allow Kingsley Gate, LLC to store and process the personal information submitted above to provide you the content requested.

I want to grow my career

I would like my candidacy to be considered for executive-level opportunities

By clicking submit below, you consent to allow Kingsley Gate, LLC to store and process the personal information submitted above to provide you the content requested.
Descargue nuestro informe completo sobre

Titular

Kingsley Gate Partners, LLC necesita la información de contacto que nos proporcione para comunicarnos con usted sobre nuestros productos y servicios. Puede darse de baja de estas comunicaciones en cualquier momento. Para obtener información sobre cómo darse de baja, así como sobre nuestras prácticas de privacidad y nuestro compromiso con la protección de su privacidad, consulte nuestra Política de privacidad.